Contribute Try STAT+ Today

The parents of a 26-year-old California man who died of an opioid overdose have sued the  manufacturer of Vivitrol, the medication he took to treat his addiction, in a case that highlights the controversies surrounding the response to the nation’s opioid crisis.

The wrongful-death suit alleges Alkermes (ALKS) failed to warn of the high risk of overdose when patients stop taking Vivitrol and then relapse into opioid use. It also claims Vivitrol is ineffective and deceptively marketed.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I have used injectable naltrexone for 4 years and it, like the other 2 MAT products are useful tools as one moves toward non use or even recovery. As they say in program “it works if you work it” and the work of recovery or non use requires persistence, discipline and a whole lot of very hard work that some are not aware of or interested in doing

Comments are closed.